Skip to main content
Log in

Early Presumptive Therapy with Fluconazole for Occult Candida Infection after Gastrointestinal Surgery

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

The objective of this retrospective comparative study was to improve the outcome of patients with suspected occult Candida infection after gastrointestinal surgery by early presumptive therapy. It was conducted in the National Cheng Kung University Hospital in Taiwan. A total of 36 patients with prolonged ileus with fever after gastrointestinal tract surgery between January 1995 and December 2002 were examined for two time periods: those treated before and those treated after January 1999. One set of patients did not receive early presumptive therapy (EPT) until Candida infection was confirmed, and they were designated EPT(−). Another group of patients with suspected occult Candida infection received EPT and were designated EPT(+). Fluconazole, 400 mg/day, was given as EPT. Urine, wound, intraperitoneal drainage, and blood specimens were obtained from patients for fungus culture before starting treatment and weekly until symptoms subsided. The primary endpoints were the frequency of candidiasis and the persistence of candidemia; the secondary endpoint was the efficiency of EPT in the clinical outcome. There was no difference in Candida peritonitis, wound colonization, or urine colonization in the two treatment groups. Candida albicans accounted for 87.5%% of the isolated Candida species: 84.6%% in the EPT(+) group and 89.5%% in the EPT(−) group. In the EPT(+) group, the positive blood culture rate was 66.7%%. The fever subsided rapidly in 17 patients (94%%), the hospital stay and intensive care unit stay were shorter, and the mortality decreased significantly: 11%% vs. 78%%, P < 0.001. Persistent gastrointestinal ileus was the main cause of breakthrough candidemia. We concluded that EPT with fluconazole improves the prognosis of patients with occult Candida infection after gastrointestinal surgery. Surgical intervention was required in patients with breakthrough candidemia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Banerjee SN, Emori TG, Culver DH et al. Secular trends in nosocomial primary blood-stream infections in the United States, 1980–1989. Am J Med 1989;91(Suppl. 3B):86S–89S

    Google Scholar 

  2. Beck-Sague CM, Jarvis WR, National Nosocomial Infections Surveillence System: secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980–1990. J Infect Dis 1993;167:1247–1251

    PubMed  CAS  Google Scholar 

  3. Wey SB, Mori M, Pfaller MA, et al. Hospital-acquired candidemia: the attributable mortality and excess length of stay. Arch Intern Med 1988;148:2642–2645

    Article  PubMed  CAS  Google Scholar 

  4. Solomkin JS, Flohr AM, Simmons RL. Indications for therapy for fungemia in postoperative patients. Arch Surg 1982;117:1272–1275

    PubMed  CAS  Google Scholar 

  5. Pittet D, Monod M, Suter PM, et al. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994;220:751–758

    PubMed  CAS  Google Scholar 

  6. Marshall JC, Christou NV, Meakins JL. The gastrointestinal tract: the “undrained abscess” of multiple organ failure. Ann Surg 1993;218:111–119

    PubMed  CAS  Google Scholar 

  7. Stone HH, Kolb LD, Currie CA, et al. Candida sepsis: pathogenesis and principles of treatment. Ann Surg 1974;179:697–711

    PubMed  CAS  Google Scholar 

  8. Volkheimer G, Schultz FH. The phenomenon of persorption. Digestion 1968;1:213–218

    Article  PubMed  CAS  Google Scholar 

  9. Stone HH, Geheber CE, Kolb LD, et al. Alimentary tract colonization by Candida albicans. J Surg Res 1973;14:273–276

    PubMed  CAS  Google Scholar 

  10. Dean DA, Burchard KW. Surgical perspective on invasive Candida infection. World J Surg 1998;22:127–134

    Article  PubMed  CAS  Google Scholar 

  11. Rex JH, Walsh TJ, Sobel JD, et al. Practice guideline for the treatment of candidiasis. Clin Infect Dis 2000;30:662–678

    Article  PubMed  CAS  Google Scholar 

  12. Solomkin JS, Flohr A, Simmons RL. Candida infection in surgical patients: does requirements and toxicity of amphotericin B. Ann Surg 1981;195:177–185

    Google Scholar 

  13. Eubanks PJ, de Virgilio C, Klein S, et al. Candida sepsis in surgical patients. Am J Surg 1993;166:617–620

    PubMed  CAS  Google Scholar 

  14. Marsh PK, Tally FP, Kellum J, et al. Candida infections in surgical patients. Ann Surg 1983;198:42–47

    PubMed  CAS  Google Scholar 

  15. Burchard KW, Minor LB, Slotman GJ, et al. Fungal sepsis in surgical patients. Arch Surg 1983;118:217–221

    PubMed  CAS  Google Scholar 

  16. Wingard JR, Merz WG, Rinaldi MG, et al. Increase in Candida kruzei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1992;325:1274–1277

    Google Scholar 

  17. Rex JH, Bennett JE, Sugar AM, et al. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N Engl J Med 1994;331:1325–1330

    Article  PubMed  CAS  Google Scholar 

  18. Nassoura Z, Ivatury RR, Simon RJ, et al. Candidiuria as an early marker of disseminated infection in critically ill surgical patients: the role of fluconazole therapy. J Trauma 1993;35:290–295

    PubMed  CAS  Google Scholar 

  19. Edwards JE, Filler SG. Current strategies for treating invasive candidiasis: emphasis on infections in nonneutropenic patients. Clin Infect Dis 1992;14(Suppl. 1):106–113

    Google Scholar 

  20. Edwards JE Jr, Bodey GP, Bowden RA, et al. International conference for the development of a consensus on the management and prevention of severe candidal infection. Clin Infect Dis 1997;25:43–49

    PubMed  Google Scholar 

  21. Edward JE Jr, Drutz DJ, Bennett JE, et al. Disseminated Candidasis: a Major Problem in Cancer and Postoperative Patients, New York, Academy Professional Information Services, 1986

    Google Scholar 

  22. Woods GL, Washington JA. Antibacterial susceptibility tests: dilution and disk diffusion methods. In: Murray PR, Baron EJ, Pfaller MA, et al (eds). Manual of Clinical Microbiology, 6th edition, Washington DC, American Society for Microbiology Press, 1995;pp 1327–1341

    Google Scholar 

  23. Eggimann P, Francioli P, Bille J, et al. Fluconazole prophylaxis prevents intraabdominal candidiasis in high-risk surgical patients. Crit Care Med 1999;27:1066–1072

    PubMed  CAS  Google Scholar 

  24. Calandra T, Bille J, Schneider R, et al. Clinical significance of Candida isolated from peritoneum in surgical patients. Lancet 1989;2:1437–1440

    PubMed  CAS  Google Scholar 

  25. Blumberg EA, Reboli AC. Failure of systemic empirical treatment with amphotericin B to prevent candidemia in neutropenic patients with cancer. Clin Infect Dis 1996;22:462–466

    PubMed  CAS  Google Scholar 

  26. Eras P, Goldstein M, Sherlock P. Candida infection of the gastrointestinal tract. Medicine (Baltimore) 1972;51:367–379

    CAS  Google Scholar 

  27. Chang T, Lu R, Tsai L. Glutamine ameliorates mechanical obstruction-induced intestinal injury. J Surg Res 2001;95:133–140

    PubMed  CAS  Google Scholar 

  28. Prabhu R, Anup R, Balasubramanian KA. Surgical stress induces phospholipid degradation in the intestinal brush border membrane. J Surg Res 2000;94:178–184

    Article  PubMed  CAS  Google Scholar 

  29. Bayer AD, Blumenkrantz MJ, Montgomerie JZ, et al. Candida peritonitis: report of 22 cases and review of the English literature. Am J Med 1976;61:832–840

    PubMed  CAS  Google Scholar 

  30. Savino JA, Agarwal N, Wry P, et al. Route prophylactic antifungal agents (clotrimazole, ketoconazole, and ny0statin) in nontransplant/nonburned critically ill surgical and trauma patients. J Trauma 1994;36:20–26

    Article  PubMed  CAS  Google Scholar 

  31. Goodman JL, Winston DJ, Greenfield RA, et al. A controlled trial of fluconazole to prevent fungal infection in patients undergoing bone marrow transplantation. N Engl J Med 1992;326:845–851

    Article  PubMed  CAS  Google Scholar 

  32. Ghannoum MA, Rex JH, Galgiani JN. Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome. J Clin Microbiol 1996;34:489–495

    PubMed  CAS  Google Scholar 

  33. Ersin S, Tuncyurek P, Esassolak M, et al. The prophylactic and therapeutic effects of glutamine- and arginine-enriched diets on radiation-induced enteritis in rats. J Surg Res 2000;89:121–125

    Article  PubMed  CAS  Google Scholar 

  34. Ward DT, Lawson SA, Gallagher CM, et al. Sustained nitric oxide production via l-arginine administration ameliorates effects of intestinal ischemia-reperfusion. J Surg Res 2000;89:13–19

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jenq-Chang Lee MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shan, YS., Sy, E.D., Wang, ST. et al. Early Presumptive Therapy with Fluconazole for Occult Candida Infection after Gastrointestinal Surgery. World J. Surg. 30, 119–126 (2006). https://doi.org/10.1007/s00268-005-7807-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-005-7807-z

Keywords

Navigation